Skip to main content
Signal8

DOYLE WILLIAM F

SEC insider (Form 3/4/5 filer). CIK 0001194459. Director at PROKIDNEY CORP. (PROK) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on May 28, 2026. Located in WAYNE, PA.

Companies DOYLE WILLIAM F has filed insider reports for

  • PROKIDNEY CORP. (PROK): Director
  • NovoCure Ltd (NVCR): Director, Officer, Executive Chairman
  • Elanco Animal Health Inc (ELAN): Director
DOYLE WILLIAM F profile photo

DOYLE WILLIAM F

CIK: 0001194459

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

PROKIDNEY CORP. logo
PROK

PROKIDNEY CORP.

Director
NovoCure Ltd logo
NVCR

NovoCure Ltd

DirectorOfficer
Elanco Animal Health Inc logo
ELAN

Elanco Animal Health Inc

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • PROKIDNEY CORP. logo
    PROK

    PROKIDNEY CORP.

    May 28, 2026
    Award

    Director stock option (right to buy)

    Direct
    135K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 3, 2026
    Award
    Direct
    200.3K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 3, 2026
    Sale
    Direct
    50.6K shares at avg. $12.79$646K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 3, 2026
    Award
    Direct
    200K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 3, 2026
    Sale
    Direct
    21.3K shares at avg. $13.43$286K
  • PROKIDNEY CORP. logo
    PROK

    PROKIDNEY CORP.

    May 29, 2025
    Award

    Director stock option (right to buy)

    Direct
    125.9K shares-
  • Elanco Animal Health Inc logo
    ELAN

    Elanco Animal Health Inc

    Nov 29, 2024
    Award
    Direct
    18.2K shares-

1-7 of 7